Anzeige
Mehr »
Sonntag, 29.06.2025 - Börsentäglich über 12.000 News
Diese KI-Biotech-Aktie revolutioniert die Krebstherapie: Lernen Sie Rakovina Therapeutics kennen
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A2PV00 | ISIN: CNE100003PG4 | Ticker-Symbol: 17Q1
Tradegate
26.06.25 | 12:26
1,740 Euro
0,00 % 0,000
Branche
Pharma
Aktienmarkt
ASIEN
1-Jahres-Chart
PHARMARON BEIJING CO LTD Chart 1 Jahr
5-Tage-Chart
PHARMARON BEIJING CO LTD 5-Tage-Chart
RealtimeGeldBriefZeit
1,6901,79028.06.
1,6901,79027.06.

Aktuelle News zur PHARMARON BEIJING Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
20.06.PHARMARON (03759): (UPDATED) FINAL DIVIDEND IN CASH FOR THE YEAR ENDED DECEMBER 31, 2024-
20.06.PHARMARON (03759): ARTICLES OF ASSOCIATION4
PHARMARON BEIJING Aktie jetzt für 0€ handeln
20.06.PHARMARON (03759): LIST OF DIRECTORS AND THEIR ROLES AND FUNCTIONS-
20.06.PHARMARON (03759): (I) POLL RESULTS OF THE ANNUAL GENERAL MEETING OF 2024, THE FIRST A SHARE CLASS MEETING OF 2025 AND THE FIRST H SHARE CLASS MEETING ...-
10.06.M Stanley Lists PHARMARON as Top Pick Among Mid-cap CRO/CDMOs, Upbeat on JOINN/TIGERMED in LT3
03.06.PHARMARON (03759): SUPPLEMENTAL ANNOUNCEMENT IN RELATION TO THE PREVIOUS ANNUAL REPORTS OF THE COMPANY-
29.05.PHARMARON (03759): (UPDATED) FINAL DIVIDEND IN CASH FOR THE YEAR ENDED DECEMBER 31, 20241
29.05.PHARMARON (03759): NOTIFICATION LETTER AND REQUEST FORM TO NON-REGISTERED SHAREHOLDERS - NOTIFICATION OF PUBLICATION OF CIRCULAR AND NOTICES FOR THE 2024 ...2
29.05.PHARMARON (03759): NOTIFICATION LETTER AND REQUEST FORM TO H SHAREHOLDERS - NOTIFICATION OF PUBLICATION OF CIRCULAR, NOTICES AND PROXY FORMS FOR THE 2024 ...1
29.05.PHARMARON (03759): FORM OF PROXY FOR THE FIRST H SHARE CLASS MEETING OF 20252
29.05.PHARMARON (03759): FORM OF PROXY FOR THE ANNUAL GENERAL MEETING OF 2024 (APPLICABLE TO H SHAREHOLDERS)1
29.05.PHARMARON (03759): NOTICE OF THE FIRST H SHARE CLASS MEETING OF 20252
29.05.PHARMARON (03759): NOTICE OF THE ANNUAL GENERAL MEETING OF 20241
29.05.PHARMARON (03759): CIRCULAR FOR THE 2024 ANNUAL GENERAL MEETING AND 2025 FIRST H SHARE CLASS MEETING1
12.05.TheraCryf partners with Pharmaron to develop addiction programme4
29.04.PHARMARON (03759): NOTIFICATION LETTER AND REQUEST FORM TO NON-REGISTERED HOLDERS - NOTICE OF PUBLICATION OF 2024 ANNUAL REPORT AND 2024 ENVIRONMENTAL, ...-
29.04.PHARMARON (03759): NOTIFICATION LETTER AND REQUEST FORM TO H SHAREHOLDERS - NOTICE OF PUBLICATION OF 2024 ANNUAL REPORT AND 2024 ENVIRONMENTAL, SOCIAL ...-
29.04.PHARMARON (03759): 2024 ENVIRONMENTAL, SOCIAL AND GOVERNANCE REPORT1
29.04.PHARMARON (03759): SUPPLEMENTAL ANNOUNCEMENT IN RELATION TO RESIGNATION AND CESSATION OF OFFICE OF NON-EXECUTIVE DIRECTOR-
29.04.PHARMARON (03759): 2024 ANNUAL REPORT-
Weiter >>
33 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1